Status:
TERMINATED
Effectiveness of Online ACT for Pain Interference in Cancer Survivors With Chronic Painful CIPN
Lead Sponsor:
Daniëlle van de Graaf
Collaborating Sponsors:
Dutch Cancer Society
Comprehensive Cancer Centre The Netherlands
Conditions:
Chemotherapy-induced Peripheral Neuropathy
Cancer Survivors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale: An average of 30% of adult cancer survivors suffers from chemotherapy-induced peripheral neuropathy (CIPN) ≥ 6 months after completion of chemotherapy, and their quality of life (QoL) is st...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- age of 18 years or older,
- identified by a clinician or self as having painful sensations (i.e., aching, burning, ''pins-and-needles'', shock-like, painful tingling, numbness, cramps) bilaterally in the feet/legs and/or hands/arms for at least 3 months. Furthermore,
- score a 3 or higher on an 11-point pain intensity scale (Numeric Rating Scale),
- the pain was not present prior to receiving chemotherapy,
- chemotherapy ended at least 6 months ago.
- Exclusion criteria:
- enrollment in psychological treatment related to cancer, pain, or psychiatry upon entry,
- new chemotherapy scheduled during study participation,
- no access to the Internet/no email address,
- not enough time to follow the intervention (2 hours per week),
- problems with the Dutch language.
Exclusion
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT05371158
Start Date
December 1 2021
End Date
July 1 2024
Last Update
August 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tilburg University
Tilburg, North Brabant, Netherlands, 5037AB